Actively Recruiting
Understanding Clinical and Molecular Factors in Chronic Inflammatory Skin Diseases Through Long-Term Observation
Led by University Hospital Schleswig-Holstein · Updated on 2026-08-28
1000
Participants Needed
1
Research Sites
35 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating chronic inflammatory skin diseases including atopic dermatitis, psoriasis, hidradenitis suppurativa, cutaneous lupus erythematosus, lichen planus, vitiligo, alopecia areata, prurigo nodularis, and rosacea. These diseases show wide variations in onset, symptoms, severity, triggers, and treatment responses, making diagnosis and management challenging. The study aims to identify clinical and molecular factors that relate to disease types, progression, and patient subgroups through long-term detailed observation. This observational study involves patients receiving routine clinical care with topical and systemic drugs treatment decisions are made independently by their doctors. Participants will be followed over time without altering their treatments. Researchers will collect clinical data and biological samples repeatedly to understand disease changes, molecular profiles, and flare-up mechanisms. Participants will undergo scheduled assessments including physician and patient evaluations of disease activity at baseline, weeks 2 and 4, and every three months for up to two years. Molecular features will also be analyzed at these times. The study includes clinical characterization, sample collection, questionnaires, and long-term monitoring to better understand disease dynamics and improve individualized care.
CONDITIONS
Brief Title
Determinants of Chronic Inflammatory Skin Disease Trajectories
Research Team
S
Stephan Weidinger, MD
S
Stefanie Sievers
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here